Breaking News
Top News
-
United Therapeutics price target raised to $519 from $471 at Morgan Stanley
-
Gilead price target raised to $175 from $171 at Morgan Stanley
-
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid
-
Vertex Pharmaceuticals price target raised to $612 from $596 at Morgan Stanley
-
Better iShares Bond ETF: IEI vs. MUB
-
We asked our wedding guests to give money to St. Jude’s Children’s Hospital. Can we write off their donations?
-
Here’s a look at the known damage to Gulf energy facilities as the U.S. and Iran meet for talks
-
Man arrested on suspicion of murder after death of 21-year-old in Primrose Hill
-
Jubilant return of Artemis II shadowed by ‘extinction-level’ cuts to Nasa: ‘It’s discordant’
-
How to Fight a War in Space
-
“Oil Demand Is About To Spike… We’re Looking At A Volatile Summer” Says Schork
-
By The Way | Buzzballs, Masters Garden Gnomes, HOA Fees
-
How to Rebuild Your Business After Losing Everything
-
S&P 500 is back above a key level, putting stock market bulls in control: Chart of the Day
-
S&P Futures Waver With All Eyes on Key U.S. Inflation Data, U.S.-Iran Talks Awaited
-
Why Shares of Nebius Group Are Skyrocketing This Week
-
Amazon CEO Andy Jassy’s shareholder letter boosts analyst confidence in AI trajectory
-
G Mining Ventures to acquire G2 Goldfields
-
Bitget Offers Retail Synthetic SpaceX Exposure, but Risks Lurk in the Details
-
2 Recession Resistant Dividend Stocks to Buy Now While They’re Still Cheap
2026-02-05


































